TRANSGELIN-2 AS A COMMON TARGET OF TUMOR SUPPRESSIVE MIR-1 AND MIR-133A IN RENAL CELL CARCINOMA

被引:0
|
作者
Kawakami, Kazumori
Chiyomaru, Takeshi
Enokida, Hideki
Tatarano, Shuichi
Yoshino, Hirofumi
Nishiyama, Kenryu
Seki, Naohiko
Nakagawa, Masayuki
机构
来源
JOURNAL OF UROLOGY | 2011年 / 185卷 / 04期
关键词
D O I
10.1016/j.juro.2011.02.176
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
110
引用
收藏
页码:E46 / E47
页数:2
相关论文
共 50 条
  • [1] The functional significance of miR-1 and miR-133a in renal cell carcinoma
    Kawakami, Kazumori
    Enokida, Hideki
    Chiyomaru, Takeshi
    Tatarano, Shuichi
    Yoshino, Hirofumi
    Kagara, Ichiro
    Gotanda, Takenari
    Tachiwada, Tokushi
    Nishiyama, Kenryu
    Nohata, Nijiro
    Seki, Naohiko
    Nakagawa, Masayuki
    EUROPEAN JOURNAL OF CANCER, 2012, 48 (06) : 827 - 836
  • [2] Identification of novel molecular targets regulated by tumor suppressive miR-1/miR-133a in maxillary sinus squamous cell carcinoma
    Nohata, Nijiro
    Hanazawa, Toyoyuki
    Kikkawa, Naoko
    Sakurai, Daiju
    Sasaki, Keita
    Chiyomaru, Takeshi
    Kawakami, Kazumori
    Yoshino, Hirofumi
    Enokida, Hideki
    Nakagawa, Masayuki
    Okamoto, Yoshitaka
    Seki, Naohiko
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2011, 39 (05) : 1099 - 1107
  • [3] miR-145, miR-133a and miR-133b: tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma
    Kano, Masayuki
    Seki, Naohiko
    Kikkawa, Naoko
    Fujimura, Lisa
    Hoshino, Isamu
    Akutsu, Yasunori
    Chiyomaru, Takeshi
    Enokida, Hideki
    Nakagawa, Masayuki
    Matsubara, Hisahiro
    INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (12) : 2804 - 2814
  • [4] THE TUMOR SUPPRESSIVE MIRNA CLUSTER OF MIR-1 AND MIR-133A TARGETS ONCOGENIC TAGLN2 GENE IN BLADDER CANCER
    Yoshino, Hirofumi
    Chiyomaru, Takeshi
    Enokida, Hideki
    Kawakami, Kazumori
    Tatarano, Shuichi
    Nishiyama, Kenryu
    Seki, Naohiko
    Nakagawa, Masayuki
    JOURNAL OF UROLOGY, 2011, 185 (04): : E541 - E541
  • [5] The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer
    Yoshino, H.
    Chiyomaru, T.
    Enokida, H.
    Kawakami, K.
    Tatarano, S.
    Nishiyama, K.
    Nohata, N.
    Seki, N.
    Nakagawa, M.
    BRITISH JOURNAL OF CANCER, 2011, 104 (05) : 808 - 818
  • [6] ONCOGENIC LASP1 IS DIRECTLY REGULATED BY THE TUMOR SUPPRESSIVE MICRORNAS (MIR-1, MIR-218, AND MIR-133A) IN BLADDER CANCER
    Chiyomaru, T.
    Kawakami, K.
    Enokida, H.
    Tatarano, S.
    Eura, R.
    Nishiyama, K.
    Seki, N.
    Nakagawa, M.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 79 - 79
  • [7] The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer
    H Yoshino
    T Chiyomaru
    H Enokida
    K Kawakami
    S Tatarano
    K Nishiyama
    N Nohata
    N Seki
    M Nakagawa
    British Journal of Cancer, 2011, 104 : 808 - 818
  • [8] Role of miR-1 and miR-133a in myocardial ischemic postconditioning
    Bin He
    Jian Xiao
    An-Jing Ren
    Yu-Feng Zhang
    Hao Zhang
    Min Chen
    Bing Xie
    Xiao-Gang Gao
    Ying-Wei Wang
    Journal of Biomedical Science, 18
  • [9] Role of miR-1 and miR-133a in myocardial ischemic postconditioning
    He, Bin
    Xiao, Jian
    Ren, An-Jing
    Zhang, Yu-Feng
    Zhang, Hao
    Chen, Min
    Xie, Bing
    Gao, Xiao-Gang
    Wang, Ying-Wei
    JOURNAL OF BIOMEDICAL SCIENCE, 2011, 18
  • [10] Tumor suppressors miR-1 and miR-133a target the oncogenic function of purine nucleoside phosphorylase (PNP) in prostate cancer
    Kojima, S.
    Chiyomaru, T.
    Kawakami, K.
    Yoshino, H.
    Enokida, H.
    Nohata, N.
    Fuse, M.
    Ichikawa, T.
    Naya, Y.
    Nakagawa, M.
    Seki, N.
    EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E842 - U777